Merck & Co., Inc.

MRK

Merck & Co., Inc. (MRK) is a global healthcare company specializing in pharmaceuticals, vaccines, and biologic therapies. Founded in 1891, it is known for developing innovative medicines across various therapeutic areas including oncology, infectious diseases, cardiology, and immunology. Merck focuses on research and development to improve health outcomes worldwide.

$127.50 -0.12 (-0.09%)

Dividend Yield 2.64%

Payout Frequency Quarterly

Dividend History

Pay Date	Amount	Ex-Date	Record Date
July 8, 2026	$0.85	2026-06-15	2026-06-15
April 7, 2026	$0.85	2026-03-16	2026-03-16
January 8, 2026	$0.85	2025-12-15	2025-12-15
October 7, 2025	$0.81	2025-09-15	2025-09-15
July 8, 2025	$0.81	2025-06-16	2025-06-16
April 7, 2025	$0.81	2025-03-17	2025-03-17
January 8, 2025	$0.81	2024-12-16	2024-12-16
October 7, 2024	$0.77	2024-09-16	2024-09-16
July 8, 2024	$0.77	2024-06-17	2024-06-17
April 5, 2024	$0.77	2024-03-14	2024-03-15
January 8, 2024	$0.77	2023-12-14	2023-12-15
October 6, 2023	$0.73	2023-09-14	2023-09-15
July 10, 2023	$0.73	2023-06-14	2023-06-15
April 10, 2023	$0.73	2023-03-14	2023-03-15
January 9, 2023	$0.73	2022-12-14	2022-12-15
October 7, 2022	$0.69	2022-09-14	2022-09-15
July 8, 2022	$0.69	2022-06-14	2022-06-15
April 7, 2022	$0.69	2022-03-14	2022-03-15
January 7, 2022	$0.69	2021-12-14	2021-12-15
October 7, 2021	$0.65	2021-09-14	2021-09-15
July 7, 2021	$0.65	2021-06-14	2021-06-15
April 7, 2021	$0.65	2021-03-12	2021-03-15
January 8, 2021	$0.65	2020-12-14	2020-12-15
October 7, 2020	$0.61	2020-09-14	2020-09-15
July 7, 2020	$0.61	2020-06-12	2020-06-15
April 7, 2020	$0.61	2020-03-13	2020-03-16
January 8, 2020	$0.61	2019-12-13	2019-12-16
October 7, 2019	$0.55	2019-09-13	2019-09-16
July 8, 2019	$0.55	2019-06-14	2019-06-17
April 5, 2019	$0.55	2019-03-14	2019-03-15
January 8, 2019	$0.55	2018-12-14	2018-12-17
October 5, 2018	$0.48	2018-09-14	2018-09-17
July 9, 2018	$0.48	2018-06-14	2018-06-15
April 6, 2018	$0.48	2018-03-14	2018-03-15
January 8, 2018	$0.48	2017-12-14	2017-12-15
October 6, 2017	$0.47	2017-09-14	2017-09-15
July 10, 2017	$0.47	2017-06-13	2017-06-15
April 7, 2017	$0.47	2017-03-13	2017-03-15
January 9, 2017	$0.47	2016-12-13	2016-12-15
October 7, 2016	$0.46	2016-09-13	2016-09-15
July 8, 2016	$0.46	2016-06-13	2016-06-15
April 7, 2016	$0.46	2016-03-11	2016-03-15
January 8, 2016	$0.46	2015-12-11	2015-12-15
October 7, 2015	$0.45	2015-09-11	2015-09-15
July 8, 2015	$0.45	2015-06-11	2015-06-15
April 8, 2015	$0.45	2015-03-12	2015-03-16
January 8, 2015	$0.45	2014-12-11	2014-12-15
October 7, 2014	$0.44	2014-09-11	2014-09-15
July 8, 2014	$0.44	2014-06-12	2014-06-16
April 7, 2014	$0.44	2014-03-13	2014-03-17
January 8, 2014	$0.44	2013-12-12	2013-12-16
October 7, 2013	$0.43	2013-09-12	2013-09-16
July 8, 2013	$0.43	2013-06-13	2013-06-17
April 5, 2013	$0.43	2013-03-13	2013-03-15
January 8, 2013	$0.43	2012-12-13	2012-12-17
October 5, 2012	$0.42	2012-09-13	2012-09-17
July 9, 2012	$0.42	2012-06-13	2012-06-15
April 6, 2012	$0.42	2012-03-13	2012-03-15
January 9, 2012	$0.42	2011-12-13	2011-12-15
October 7, 2011	$0.38	2011-09-13	2011-09-15
July 8, 2011	$0.38	2011-06-13	2011-06-15
April 7, 2011	$0.38	2011-03-11	2011-03-15
January 7, 2011	$0.38	2010-12-13	2010-12-15
October 7, 2010	$0.38	2010-09-13	2010-09-15
July 8, 2010	$0.38	2010-06-11	2010-06-15
April 7, 2010	$0.38	2010-03-11	2010-03-15
January 8, 2010	$0.38	2009-12-11	2009-12-15
October 1, 2009	$0.38	2009-09-02	2009-09-04
July 1, 2009	$0.38	2009-06-04	2009-06-08
April 1, 2009	$0.38	2009-03-04	2009-03-06
January 2, 2009	$0.38	2008-12-03	2008-12-05
October 1, 2008	$0.38	2008-09-03	2008-09-05
July 1, 2008	$0.38	2008-06-04	2008-06-06
April 1, 2008	$0.38	2008-03-05	2008-03-07
January 2, 2008	$0.38	2007-12-05	2007-12-07
October 1, 2007	$0.38	2007-09-05	2007-09-07
July 2, 2007	$0.38	2007-06-06	2007-06-08
April 2, 2007	$0.38	2007-03-07	2007-03-09
January 2, 2007	$0.38	2006-12-06	2006-12-08
October 2, 2006	$0.38	2006-08-30	2006-09-01
July 3, 2006	$0.38	2006-05-31	2006-06-02
April 3, 2006	$0.38	2006-03-08	2006-03-10
January 3, 2006	$0.38	2005-11-30	2005-12-02
October 3, 2005	$0.38	2005-08-31	2005-09-02
July 1, 2005	$0.38	2005-06-01	2005-06-03
April 1, 2005	$0.38	2005-03-02	2005-03-04
January 3, 2005	$0.38	2004-12-01	2004-12-03
October 1, 2004	$0.38	2004-09-01	2004-09-03
July 1, 2004	$0.37	2004-06-02	2004-06-04
April 1, 2004	$0.37	2004-03-03	2004-03-05
January 2, 2004	$0.37	2003-12-03	2003-12-05

Dividends Summary

Consistent Payer: Merck & Co., Inc. has rewarded shareholders with 91 dividend payments over the past 22 years.
Total Returned Value: Investors who held MRK shares during this period received a total of $46.52 per share in dividend income.
Latest Payout: The most recent dividend of $0.85/share was paid 10 days ago, on July 8, 2026.
Yield & Schedule: MRK currently pays dividends quarterly with an annual yield of 2.64%.
Dividend Growth: Since 2004, the dividend payout has grown by 129.7%, from $0.37 to $0.85.
Dividend Reliability: MRK has maintained or increased its dividend for 91 consecutive payments.

Company News

Autoimmune Disease Therapeutics Market Size to Reach USD 137.85 Billion by 2035 as Biologics and Precision Medicine Drive Growth | SNS Insider

GlobeNewswire Inc. • Sns Insider • July 15, 2026

The global autoimmune disease therapeutics market is projected to grow from USD 80.54 billion in 2025 to USD 137.85 billion by 2035, with a CAGR of 5.52%. Growth is driven by rising prevalence of autoimmune diseases, adoption of biologics, JAK inhibitors, monoclonal antibodies, and precision medicine technologies. North America leads with 39.96% ...

ABBV NVS AMGN JNJ PFE BMY

Slate Medicines Strengthens Board of Directors with Appointment of Mark W. Hahn

GlobeNewswire Inc. • Na • July 15, 2026

Slate Medicines, a biotech company developing migraine treatments, announced the appointment of Mark W. Hahn to its Board of Directors. Hahn brings over 25 years of life sciences leadership experience, including serving as CFO at Verona Pharma during its $10 billion acquisition by Merck in 2025. His appointment comes as Slate advances SLTE-1009, ...

Oral Obesity Therapies Market to Reach $6.32 Billion by 2030 as Demand for GLP-1 Treatments Accelerates

GlobeNewswire Inc. • Researchandmarkets.Com • July 15, 2026

The global oral obesity therapies market is projected to grow from $4.32 billion in 2026 to $6.32 billion by 2030, with a compound annual growth rate of 9.9%. The market expansion is driven by increasing demand for GLP-1 treatments, combination therapies, personalized metabolic treatments, and telehealth-enabled prescribing. Key opportunities inc...

NVO LLY PFE AZN

Head and Neck Squamous Cell Carcinoma Market is Projected to Boost at a CAGR of 10.5% During the Forecast Period (2026–2036) Due to the Launch of Emerging Novel Immunotherapies | DelveInsight

GlobeNewswire Inc. • Na • July 13, 2026

The head and neck squamous cell carcinoma (HNSCC) market is expected to grow at a CAGR of 10.5% from 2026-2036, driven by rising cancer incidence, increased adoption of immunotherapies, and the launch of emerging novel treatments. The market was valued at USD 850 million in 2025 across seven major markets, with KEYTRUDA currently generating the h...

JNJ BNTX GMAB IMMP CUE EDGE

Cosmos Health Accelerates Prescription Medicine Strategy with Libytec Partnership to Commercialize DIABIT-IS X in Greece

GlobeNewswire Inc. • Na • July 13, 2026

Cosmos Health has partnered with Libytec Pharmaceutical to commercialize DIABIT-IS X (sitagliptin), a generic diabetes medication, in Greece. Under a five-year agreement, Cosmos will supply the drug while Libytec handles distribution and promotion. As a prescription medicine covered by Greece's national health insurance system, DIABIT-IS X is pos...